The use of cocaine and crack during pregnancy and its effects on newborns and children: a systematic review protocol

Authors

DOI:

https://doi.org/10.33233/fb.v24i5.5480

Keywords:

pregnancy, Drug abuse, crack, cocaine, newborn

Abstract

Introduction: The use of illicit drugs represents an important public health problem in the world, especially when it comes to developing countries like Brazil. Objective: To evaluate the effects of cocaine exposure in utero on the motor development and mortality in newborns and children. Methods: We will carry out a systematic review including observational studies (cohort or case-control), published in full text or just as an abstract. The study protocol will be registered on the Prospero Platform. We will include newborns and children up to 36 months of age. We will carry out searches in the following databases: Medical Literature Analysis and Retrieval System Online (Medline) via Pubmed, Excerpta Medica dataBASE (Embase) via Elsevier, Cochrane Central Register of Controlled Trials (CENTRAL) via Cochrane Library, Latin American Literature and the Caribbean in Health Sciences (Lilacs) via the Virtual Health Library Portal and Physiotherapy Evidence Database (PEDro), with no restrictions on language or year of publication. We will assess the methodological rigor of the included studies and the certainty of the evidence of the main results of the systematic review using the Cochrane ROBINS-E- Risk of Bias in Non- randomized Studies- of Exposure (ROBINS-E) tool and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, respectively. Two independent investigators will perform the selection of studies, data extraction, assessment of the risk of bias of included studies and assessment of the certainty of evidence. Expected Results: The results of this review are expected to summarize the best scientific evidence currently available regarding the effects of cocaine and crack use during pregnancy on newborns and children, and provide useful information for clinical decision-making. Furthermore, it is believed that the results of this review may expose knowledge gaps and provide a good foundation for future high-quality studies on the subject.

Author Biographies

Ana Carolina Pereira Nunes Pinto, UNIFAP

Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brasil

Raquel Dosares Batista da Silva, UNIFAP

Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brasil

Adriana Maria Rêgo Ribeiro, UNIFAP

Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brasil

André Silva de Sousa, UNIFAP

Bolsista do Programa Institucional de Bolsas de Mestrado da Coordenação de Aperfeiçoamento de pessoal de Nível Superior – CAPES, Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brasil

Reinaldo Oliveira Cunha, UNIFAP

Bolsista do Programa Institucional de Bolsas de Iniciação em Desenvolvimento Tecnológico e Inovação – CNPq, Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brasil

Fernanda Gabriella de Siqueira, UNIFAP

Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brasil

Juliana Anézia Rodrigues do Amaral, UNIFAP

Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brasil

References

Guimarães RA, Souza MM, Caetano KAA, Teles SA, Matos MA. Use of illicit drugs by adolescents and young adults of an urban settlement in Brazil. Rev Assoc Med Bras. 2018;64(2):114-118. doi: 10.1590/1806-9282.64.02.114

Escritório das Nações Unidas sobre Drogas e Crime. Relatório Mundial sobre Drogas 2015. 2015 [citado 2017 Jan 6]. Disponível em: https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf

Aghamohammadi A, Zafar, M. 2016. Crack abuse during pregnancy: Maternal, fetal and neonatal complication. Journal of Maternal-Fetal and Neonatal Medicine 2016;29(5):795–97. doi: 10.3109/14767058.2015.1018821

Dia Nacional de Combate às Drogas e ao Alcoolismo. Biblioteca Virtual em Saúde. [citado 2023 fev 20]. Disponível em: https://bvsms.saude.gov.br/20-02-dia-nacional-de-combate-as-drogas-e-ao-alcoolismo/

Santos JF, Cavalcante CMB, Barbosa FT, Gitaí GLD, Duzzioni M, Tilleli CQ, et al. Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis. Arch Gynecol Obstet. 2018;298(3):487-503. doi: 10.1007/s00404-018-4833-2

Garcia RCT, Dati LMM, Fukuda S, Torres LHL, Moura S, Carvalho, et al. 2012. Neurotoxicity of anhydroecgonine methyl ester, a crack cocaine pyrolysis product. Toxicological Sciences 2012;128(1):223–34. doi: 10.1093/toxsci/kfs140

Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L, Goldfrank LR. Associação entre a toxicidade da cocaína com risco de vida e a atividade da colinesterase plasmática. Ann Emerge Med 1992; 21:247-253.

Eduardo Tsuyoshi Yamaguchi, Mônica Maria Siaulys Capel Cardoso, Marcelo Luis Abramides,Torres Arthur Guerra de Andrade. Abuso de drogas durante a gravidez. Arch. Clin. Psychiatry. 2008;35(suppl 1). doi: 10.1590/S0101-60832008000700010

National Survey on Drug Use and Health (NSDUH-2015). [citado 20 fev 2023]. Disponível em: https://catalog.data.gov/dataset/national-survey-on-drug-use-and-health-nsduh-2015

National Survey on Drug Use and Health (NSDUH-2008). Data.Gov. [citado 20 fev 2023]. Disponível em: https://catalog.data.gov/dataset/national-survey-on-drug-use-and-health-nsduh-2008

Reis FT, Loureiro RJ. Repercussões neonatais decorrentes da exposição ao crack durante a gestação. Rev Eletrônica Saúde Mental Álcool Drog. 2015;11(4):217-24. doi: 10.11606/issn.1806-6976.v11i4p217-224

Matos JC, Mello JM, Colombo JVP, Melo SR. Efeitos neurológicos da exposição pré-natal à cocaína/crack. Arquivos do Mudi 2011;15:8-16. Disponível em: https://periodicos.uem.br/ojs/index.php/ArqMudi/article/view/21067

LENAD – II Levantamento Naciona de Álcool e outras Drogas - 2012. Organizado por: Ronaldo Laranjeira; et. al. São Paulo: Instituto Nacional de Ciência e Tecnologia para Políticas Públicas de Álcool e Outras Drogas (INPAD). UNIFESP; 1014.

National Survey on Drug Use and Health (NSDUH-2008). Data.Gov. Disponível em: https://catalog.data.gov/dataset/national-survey-on-drug-use-and-health-nsduh-2008.

Moreira DJS, Santos IM, Dunningham WA. Crack exposure during pregnancy and its maternal, fetal and neonatal repercussions: a systematic review. Revista Brasileira de Neurologia e Psiquiatria 2022 set/dez;26(3):84-90. Disponível em: http://www.revneuropsiq.com.br/rbnp/article/view/946

Burkett G, Bandstra ES, Cohen J. Cocaine-related maternal death. Am J Obstet Gynecol. 1990;163:40–41. doi: 10.1016/s0002-9378(11)90662-0

Serino, MA, Dana, Bradley S. Peterson, MD, and Tove S. Rosen, MD. Psychological functioning of women taking illicit drugs during pregnancy and the growth and development of their offspring in early childhood. Journal of Dual Diagnosis 2018;14.3:158-170. doi: 10.1080/15504263.2018.1468946

Hurt H. Crianças expostas à cocaína: acompanhamento até 30 meses. Journal of Developmental & Behavioral Pediatrics 1995;16(1):29-35.

Messinger D. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 2004;113(6):6:1677-1685. doi: 10.1542/peds.113.6.1677

Midon MZ, Gerzon LR, Almeida CS. Crack and motor development of babies living in an assistance shelter. ABCS Health Sciences. 2019. doi: 10.7322/abcshs.2019159.1428

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi: 10.1186/2046-4053-4-1

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:71. doi: 10.1136/bmj.n71

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016;5(1):210. doi: 10.1186/s13643-016-0384-4

Review Manager (RevMan). Versão 5.3. Copenhagen: Nordic Cochrane Centre, Cochrane. 2020. (computer program)

Downloads

Published

2023-10-26